Scopis, a company headquartered in Berlin, Germany, won FDA clearance for its electromagnetic navigation system for ENT surgeries.
In the next step Scopis aims to get clearance for its TGS technology, which provides visual guided paths, superimposed onto the live imaging from the endoscope, that help surgeons guide their tools safely toward difficult to reach targets.
The technology relies on Scopis’s Hybrid Navigation platform that tracks the head in real-time using optical and electromagnetic techniques, automatically aligning previously captured imagery with real-time data coming from the scope. The optical and electromagnetic techniques can be used individually or together, depending on needs and the surgical instruments being used at the time.
Here are a few videos showing off the Scopis Targeted Guided Surgery system:
Products page: Scopis TGS…
Via: Scopis…